Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 5,000 shares at $39.36 ($192K) on 2015-01-02, disclosed to the SEC on 2015-01-05.
Scheduled sale ($192k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.32 | 4,300 | $165K | 85.7% |
| 2 | $39.36 | 700 | $28K | 14.3% |
| Total | $38.47 avg | 5,000 | $192K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |